Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Appellate Court Hands Siemens Big Win In False Advertising Suit

Executive Summary

The Ninth Circuit Court of Appeals upheld a lower court’s decision that false advertising claims made against Siemens Medical Solutions by a competitor had no basis for trial.

You may also be interested in...

CMS Webpage Promotes Medicaid’s Home And Community-Based Services Across US, Including Telehealth

Through home and community-based services, Medicaid beneficiaries can receive support and tap into program services from home.

Certus Gets Funding From Pentagon To Develop Devices That Could Save Lives On The Battlefield

The US Department of Defense is helping Salt Lake City-based medical device company Certus Critical Care develop AI-enabled technology to treat catastrophic wounds on the battlefield and beyond.

Audiologist Group Has Concerns About US FDA's Proposal For OTC Sales Of Hearing Aids

With FDA proposal to allow OTC hearing aid sales mostly met with approval, American Speech-Language-Hearing Association says consumers risk further hearing loss by not consulting with professionals.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts